comparemela.com

Page 7 - Founded Entity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PureTech Health appoints Robert Lyne as Chief Portfolio Officer

PureTech Health appoints Robert Lyne as Chief Portfolio Officer

United statesCity ofUnited kingdomDaphne zoharArix bioscienceUniversity of oxfordOxford brookes universityPuretech healthRobert lyneChief portfolioChief executive officerWholly owned programsFounded entityGeneral counselChief operating officerTouchstone innovations

PureTech Health plc – Half-Year Report

PureTech Health plc – Half-Year Report
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomBen atwellBharatt chowriraDaphne zoharMary lamattinaYishai zoharJohn lamattinaNichole sarkisRob winderRaju kucherlapatiMonte carloRobert langerAkili incDrug administration

PureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week

VE303 receives Fast Track designation for prevention of recurrent C. difficile infection ahead of global pivotal Phase 3 study Exploratory analyses from the VE303 Phase 2 CONSORTIUM study identify. | May 9, 2023

United kingdomUnited statesJeffreyl silberRajita menonHuman servicesBiomedical advanced researchPuretech healthAmerican gastroenterological associationAmerican society for gastrointestinal endoscopyDepartment of healthSociety for surgery of the alimentary tractDevelopment authorityUniversity of massachusetts medical schoolSinai school of medicineDrug administrationAdministration for strategic preparedness

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: Vedanta Gets $106M+ to Advance Microbiome Pipeline

Investegate announcements from PureTech Health PLC, Vedanta Gets $106M+ to Advance Microbiome Pipeline

United kingdomSouth koreaUnited statesBharatt chowriraChristopher viehbacherNeil tiwariwillBernat olleCurt labelleAtlantic neptuneEntityvedanta biosciencesMartin heideckerJournal of the american medical associationPuretech healthBiogen incDepartment of healthKorea investment securities us inc

PureTech Founded Entity Vedanta Biosciences Announces $106 5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

Financing will enable pivotal Phase 3 study of VE303 for recurrent C. difficile infection, to begin by 3Q 2023 Funds will also support Phase 2 study of VE202 for ulcerative colitis, to begin in 2Q. | April 25, 2023

United statesSouth koreaUnited kingdomMartin heideckerAtlantic neptuneCurt labelleBernat olleChristopher viehbacherBharatt chowriraNeil tiwariDepartment of healthKorea investment securities us incBiomedical advanced researchDevelopment authorityJournal of the american medical associationPuretech health

vimarsana © 2020. All Rights Reserved.